Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Telo Genomics Corp (TDSGF)

Telo Genomics Corp (TDSGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program Newsfile - Thu Dec 18, 3:20PM CST

Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced telomere...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)
Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting Newsfile - Thu Dec 11, 3:04PM CST

Toronto, Ontario--(Newsfile Corp. - December 11, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)
Telo Genomics to Present Groundbreaking Individual-Cell Risk Assessment MRD Technology at the Myeloma Canada MRD Implementation Summit 2025 Newsfile - Thu Nov 13, 7:36AM CST

Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ("Telo" or the "Company"), a leader in diagnostic and prognostic innovation through its proprietary...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)
American Society of Hematology Accepts Telo Genomics' Abstract for Presentation at its 2025 Meeting and Exposition Newsfile - Thu Oct 9, 7:38AM CDT

Recognition highlights commercial potential of Telo's telomere-based MRD technology in the growing precision oncology marketToronto, Ontario--(Newsfile Corp. - October 9, 2025) - Telo Genomics Corp. (TSXV:...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)
Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update Newsfile - Tue Sep 30, 3:37PM CDT

Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)
Telo Geonomics Announces Engagement of Investor Relations Service Provider Newsfile - Mon Sep 8, 3:28PM CDT

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") announces that it has engaged Hayden IR, LLC. ("Hayden"),...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)
Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference Newsfile - Tue Aug 5, 3:22PM CDT

Toronto, Ontario--(Newsfile Corp. - August 5, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)
International Myeloma Society Accepts Telo Genomics' MRD Abstract for Presentation at Its 2025 Meeting Newsfile - Thu Jul 24, 7:38AM CDT

Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)
Telo Genomics Corp. to File Statement of Defence and Counterclaim to Lawsuit Filed by Former President Newsfile - Mon Jun 30, 6:02PM CDT

Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") has received a Statement of Claim filed by Sherif Louis, the former...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)
Telo Genomics Initiate Clinical Trial for Minimal Residual Disease in Multiple Myeloma Newsfile - Wed Jun 18, 7:38AM CDT

Toronto, Ontario--(Newsfile Corp. - June 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human...

TDSGF : 0.0382 (+21.27%)
TELO.VN : 0.050 (unch)

Barchart Exclusives

5 "Best of the Best" Dividend Stocks to Own in 2026 Barchart - Fri Dec 19, 6:00PM CST
These five companies come with above-average yields and buy ratings from Wall Street analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot